Covered recipient · General Payments record
ROBERT F SIDONIO
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2019 · Entire year
$151,918.80
153 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2019 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,762.40 | 27 |
| Consulting Fee | $56,826.00 | 15 |
| Travel and Lodging | $13,725.21 | 50 |
| Food and Beverage | $4,146.16 | 52 |
| Education | $459.03 | 9 |
By paying entity
PY2019 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOVERATIV THERAPEUTICS INC. | $47,514.82 | 43 |
| Genentech USA, Inc. | $31,956.71 | 35 |
| F. Hoffmann-La Roche AG | $27,180.72 | 17 |
| BioMarin Pharmaceutical Inc. | $10,068.97 | 6 |
| Shire North American Group Inc | $9,242.56 | 15 |
| Novo Nordisk Inc | $8,516.69 | 6 |
| GENZYME CORPORATION | $5,209.01 | 7 |
| APTEVO THERAPEUTICS INC | $3,791.44 | 14 |
| Spark Therapeutics, Inc. | $3,465.00 | 1 |
| SANOFI-AVENTIS U.S. LLC | $3,264.58 | 5 |
| PFIZER INC. | $1,200.00 | 1 |
| Eagle Pharmaceuticals, Inc. | $400.00 | 1 |
| Octapharma USA, Inc. | $83.50 | 1 |
| JAZZ PHARMACEUTICALS INC. | $24.80 | 1 |
Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
ROBERT F SIDONIO
NPI 1518000900 · CMS profile ID 295126
Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Hematology-Oncology
ATLANTA, GA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1518000900?year=2019&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- ROBERT F SIDONIO, NPI 1518000900, CMS profile ID 295126. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1518000900?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- APA 7
- IndustryPayments. (2026). ROBERT F SIDONIO, NPI 1518000900, CMS profile ID 295126. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1518000900?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- Bluebook
- ROBERT F SIDONIO, NPI 1518000900, CMS profile ID 295126, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 153 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1518000900?year=2019&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2019
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30
153 matching records · $151,918.80 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 153.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| BIOVERATIV THERAPEUTICS INC. | $20.00 | 08/16/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694263067 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $52.97 | 08/16/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694291997 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $4,673.00 | 08/16/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694328561 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.00 | 08/16/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694159719 | CMS |
| Genentech USA, Inc. | $300.82 | 08/09/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681414683 | CMS |
| F. Hoffmann-La Roche AG | $77.00 | 08/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681068969 | CMS |
| F. Hoffmann-La Roche AG | $94.00 | 08/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681076499 | CMS |
| F. Hoffmann-La Roche AG | $306.00 | 08/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681076599 | CMS |
| F. Hoffmann-La Roche AG | $2,170.00 | 08/08/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681076909 | CMS |
| F. Hoffmann-La Roche AG | $5,100.00 | 08/08/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681077361 | CMS |
| Genentech USA, Inc. | $23.46 | 08/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681139121 | CMS |
| Genentech USA, Inc. | $335.13 | 08/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681339137 | CMS |
| Genentech USA, Inc. | $30.00 | 08/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681341169 | CMS |
| Genentech USA, Inc. | $4,000.00 | 08/08/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681360339 | CMS |
| Genentech USA, Inc. | $728.42 | 08/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681361045 | CMS |
| Genentech USA, Inc. | $81.60 | 08/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681403125 | CMS |
| BioMarin Pharmaceutical Inc. | $8,000.00 | 08/03/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858321 | CMS |
| BioMarin Pharmaceutical Inc. | $326.20 | 08/03/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858325 | CMS |
| BioMarin Pharmaceutical Inc. | $408.12 | 08/03/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858327 | CMS |
| BioMarin Pharmaceutical Inc. | $372.12 | 08/03/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673859033 | CMS |
| BioMarin Pharmaceutical Inc. | $538.60 | 08/01/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858323 | CMS |
| JAZZ PHARMACEUTICALS INC. | $24.80 | 07/26/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 684155635 | CMS |
| APTEVO THERAPEUTICS INC | $0.54 | 07/25/2019 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651541875 | CMS |
| APTEVO THERAPEUTICS INC | $2.68 | 07/25/2019 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651541885 | CMS |
| APTEVO THERAPEUTICS INC | $5.87 | 07/13/2019 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651541877 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $4,005.00 | 07/13/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694270093 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $20.66 | 07/13/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694270095 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $152.32 | 07/13/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694270097 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $215.76 | 07/13/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694270605 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $2,937.00 | 07/09/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694177741 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.10 | 07/09/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694138319 | CMS |
| F. Hoffmann-La Roche AG | $2,640.00 | 07/08/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681069043 | CMS |
| F. Hoffmann-La Roche AG | $70.97 | 07/08/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681077125 | CMS |
| F. Hoffmann-La Roche AG | $1,655.67 | 06/30/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681069413 | CMS |
| Genentech USA, Inc. | $113.82 | 06/27/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681321535 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $4,005.00 | 06/08/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694291969 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $599.85 | 06/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694291971 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $367.93 | 06/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694291973 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $132.16 | 06/08/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694291975 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $454.29 | 06/01/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694057473 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $1,148.57 | 06/01/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694129799 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $122.39 | 05/30/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694260213 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $4,673.00 | 05/30/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694268995 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $245.25 | 05/30/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694268997 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $16.74 | 05/30/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694268999 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $337.03 | 05/30/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694269001 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $182.74 | 05/30/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694269003 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $10.00 | 05/30/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694269005 | CMS |
| APTEVO THERAPEUTICS INC | $5.61 | 05/21/2019 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 651541745 | CMS |
| Genentech USA, Inc. | $3,300.00 | 05/10/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681162835 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $9,184.20 | 3 |
| PY2025 | Principal investigator | $182,274.81 | 4 |
| PY2024 | Recipient | $3,751.00 | 2 |
| PY2024 | Principal investigator | $498,129.00 | 10 |
| PY2023 | Principal investigator | $342,098.00 | 7 |
| PY2022 | Recipient | $300.00 | 1 |
| PY2022 | Principal investigator | $2,210.00 | 1 |
| PY2021 | Recipient | $781.90 | 1 |
| PY2021 | Principal investigator | $90,676.12 | 9 |
| PY2020 | Recipient | $12,686.98 | 9 |
| PY2020 | Principal investigator | $341,594.79 | 25 |
| PY2019 | Recipient | $1,640.40 | 2 |
| PY2019 | Principal investigator | $331,472.31 | 48 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
7 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Recipient | HEMA Biologics, LLC | $7,150.00 | 11/03/2025 | Covered Recipient Physician | A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM | No dispute reported | 06/30/2026 | 1211421409 |
| Principal investigator 1 | CSL Behring | $1,044.21 | 09/19/2025 | Non-covered Recipient Entity Children's Healthcare of Atlanta Inc | Phase 3, Open-label, Single-dose, Multicenter Study Investigating Efficacy, Safety, and Tolerability of CSL222 (Etranacogene Dezaparvovec) Administered to Adolescent Male Subjects ( 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B | No dispute reported | 06/30/2026 | 1252665224 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $18,429.60 | 09/11/2025 | Covered Recipient Teaching Hospital EMORY UNIVERSITY HOSPITAL | PHASE 3, PROSPECTIVE, MULTI-CENTER, OPEN LABEL STUDY TO INVESTIGATE SAFETY, IMMUNOGENICITY, AND HEMOSTATIC EFFICACY OF PEGYLATED FACTOR VIII (BAX 855) IN PREVIOUSLY UNTREATED PATIENTS (PUPS) AND MINIMALLY TREATED PATIENTS (MTPS) < 6 YEARS WITH SEVERE HEMOPHILIA A (FVIII < 1%) | No dispute reported | 06/30/2026 | 1223266317 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $45,900.00 | 04/16/2025 | Covered Recipient Teaching Hospital EMORY UNIVERSITY HOSPITAL | A retrospective analysis of the Safety, Effectiveness during surgery with recombinant Von Willebrand Factor (rVWF) in children with Von Willebrand Disease (VWD) in the ATHNdataset | No dispute reported | 06/30/2026 | 1223266233 |
| Recipient | HEMA Biologics, LLC | $475.00 | 04/11/2025 | Covered Recipient Physician | A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM | No dispute reported | 06/30/2026 | 1211421407 |
| Recipient | F. Hoffmann-La Roche AG | $1,559.20 | 03/31/2025 | Covered Recipient Physician | Open Label Phase III Study of emicizumab in Hemophilia A Pediatrics Patients with Inhibitors | No dispute reported | 06/30/2026 | 1211538579 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $116,901.00 | 01/03/2025 | Covered Recipient Teaching Hospital EMORY UNIVERSITY HOSPITAL | A retrospective analysis of the Safety, Effectiveness during surgery with recombinant Von Willebrand Factor (rVWF) in children with Von Willebrand Disease (VWD) in the ATHNdataset | No dispute reported | 06/30/2026 | 1223266181 |